Clinical Trials Browser

Interventional × Arthritis, Rheumatoid × Tumor Necrosis Factor Inhibitors × Clear all

NCT01548768 2020-11-27

RHYTHM

Phase 4 Completed

149 enrolled 15 charts

Arthritis, Rheumatoid, Cardiovascular Diseases

NCT02862574 2018-06-27

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Phase 2 Terminated

15 enrolled 11 charts

Arthritis, Rheumatoid